Nike Inc. (NKE) - 5i Research

Nike Inc. (NKE $57.34)
- $57.34 P/E (TTM): 29.34X Cap: $84.76B
- View NKE Profile
- View Questions on NKE

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Adobe Inc. (ADBE $352.42)
- $352.42 P/E (TTM): 21.3X Cap: $147.52B
- View ADBE Profile
- View Questions on ADBE
Accenture plc Class A (Ireland) (ACN $270.77)
- $270.77 P/E (TTM): 22.41X Cap: $178.82B
- View ACN Profile
- View Questions on ACN
Nike Inc. (NKE $57.34)
- $57.34 P/E (TTM): 29.34X Cap: $84.76B
- View NKE Profile
- View Questions on NKE
Thermo Fisher Scientific Inc (TMO $579.94)
- $579.94 P/E (TTM): 32.8X Cap: $217.88B
- View TMO Profile
- View Questions on TMO
TELUS Corporation (T $17.43)
- $17.43 Cap: $26.98B
- View T Profile
- View Questions on T
IDEXX Laboratories Inc. (IDXX $682.31)
- $682.31 P/E (TTM): 55.68X Cap: $54.48B
- View IDXX Profile
- View Questions on IDXX

Q: Dear 5i,

I have a diverse portfolio with stocks and ETFs. Most of my portfolio is doing well. Want to know your thoughts about a few of my holdings that are not doing so well - Adobe, Nike, Accenture, TMO, IDXX and Telus.

What are your thoughts? Should I replace these with a US ETF or hold on. Thanks for your valuable advice as always.

Read Answer Asked by Alka on November 26, 2025

Nike Inc. (NKE $57.34)
- $57.34 P/E (TTM): 29.34X Cap: $84.76B
- View NKE Profile
- View Questions on NKE
Dollarama Inc. (DOL $204.69)
- $204.69 P/E (TTM): 43.38X Cap: $56.04B
- View DOL Profile
- View Questions on DOL
lululemon athletica inc. (LULU $212.68)
- $212.68 P/E (TTM): 14.78X Cap: $23.86B
- View LULU Profile
- View Questions on LULU
Aritzia Inc. Subordinate Voting Shares (ATZ $117.19)
- $117.19 P/E (TTM): 49.49X Cap: $13.51B
- View ATZ Profile
- View Questions on ATZ
- View Reports on ATZ
Crocs Inc. (CROX $89.98)
- $89.98 P/E (TTM): 28.96X Cap: $4.67B
- View CROX Profile
- View Questions on CROX

Q: My total allocation in my portfolio is currently at 16%. However, it is inverse what the asset allocator recommend with nearly 4% in Cyclical and over 12% in Defensive. Would you recommend shifting some within Consumer? Do what extent does this matter since the boundary between both seems somewhat artificial? FYI - I own ABEV, BKGN, DOL, FDP, SAP all in my RRSP. If you recommend that I shift into Cons Cyclical, what would recommend as of today for my RRSP (US and CAN)?

Read Answer Asked by Patrik on October 14, 2025

Nike Inc. (NKE $57.34)
- $57.34 P/E (TTM): 29.34X Cap: $84.76B
- View NKE Profile
- View Questions on NKE
iShares U.S. Small Cap Index ETF (CAD-Hedged) (XSU $48.05)
- $48.05 P/E (TTM): 17.68X Cap: $691M
- View XSU Profile
- View Questions on XSU
lululemon athletica inc. (LULU $212.68)
- $212.68 P/E (TTM): 14.78X Cap: $23.86B
- View LULU Profile
- View Questions on LULU
Vanguard FTSE Developed ex North America High Dividend Yield Index ETF (VIDY $41.37)
- $41.37 P/E (TTM): 19.13X Cap: $1.14B
- View VIDY Profile
- View Questions on VIDY

Q: Are any of these above companies worth investing in? Also if so, at what price would be a good buy.

Thank You
John G.

Read Answer Asked by John on October 07, 2025